Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Public ClinicalTrials.gov record NCT01619683. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the effects of 12 months of treatment with Androxal on bone mineral density in men with secondary hypogonadism.
Study identification
- NCT ID
- NCT01619683
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2012 (Type not available)
- Primary completion
- Sep 2014 (Actual)
- Completion
- Sep 2014 (Actual)
- Last update posted
- Oct 1, 2014
2012 – 2014
United States locations
- U.S. sites
- 17
- U.S. states
- 8
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mesa | Arizona | 85213 | — |
| Not listed | Phoenix | Arizona | 85050 | — |
| Not listed | Tempe | Arizona | 85283 | — |
| Not listed | Mission Viejo | California | 92691 | — |
| Not listed | Newport Beach | California | 92663 | — |
| Not listed | Rancho Cucamonga | California | 91730 | — |
| Not listed | Clearwater | Florida | 33761 | — |
| Not listed | Fort Lauderdale | Florida | 33308 | — |
| Not listed | Jupiter | Florida | 33458 | — |
| Not listed | Miami | Florida | 33143 | — |
| Not listed | Miami Gardens | Florida | 33169 | — |
| Not listed | Henderson | Nevada | 89052 | — |
| Not listed | Lawrenceville | New Jersey | 08690 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Rochester | New York | 14609 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01619683, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2014 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01619683 live on ClinicalTrials.gov.